Filippo Crea
doi : 10.1093/eurheartj/ehab867
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 1–5
Marko Banovic, Svetozar Putnik, Ronald Binder
doi : 10.1093/eurheartj/ehab527
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 6–8
doi : 10.1093/eurheartj/ehab754
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 9–11
Petar M Seferovic, Massimo Piepoli, Marija Polovina, Ivan Milinkovic, Giuseppe M C Rosano, Andrew J S Coats
doi : 10.1093/eurheartj/ehab734
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 11–13
Mark Nicholls
doi : 10.1093/eurheartj/ehab451
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 14–16
Giovanna Liuzzo, Carlo Patrono
doi : 10.1093/eurheartj/ehab749
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 16–17
Mario Gaudino, Antonino Di Franco, John H Alexander, Faisal Bakaeen, Natalia Egorova, Paul Kurlansky, Andreas Boening, Joanna Chikwe, Michelle Demetres, Philip J Devereaux, Anno Diegeler, Arnaldo Dimagli, Marcus Flather, Irbaz Hameed, Andre Lamy, Jennifer S Lawton, Wilko Reents, N Bryce Robinson, Katia Audisio, Mohamed Rahouma, Patrick W Serruys, Hironori Hara, David P Taggart, Leonard N Girardi, Stephen E Fremes, Umberto Benedetto
doi : 10.1093/eurheartj/ehab504
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 18–28
Data suggest that women have worse outcomes than men after coronary artery bypass grafting (CABG), but results have been inconsistent across studies. Due to the large differences in baseline characteristics between sexes, suboptimal risk adjustment due to low-quality data may be the reason for the observed differences. To overcome this limitation, we undertook a systematic review and pooled analysis of high-quality individual patient data from large CABG trials to compare the adjusted outcomes of women and men.
Sanne A E Peters, Jolanda Kluin
doi : 10.1093/eurheartj/ehab617
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 29–31
Saman L Parvar, Linh Ngo, Joseph Dawson, Stephen J Nicholls, Robert Fitridge, Peter J Psaltis, Isuru Ranasinghe
doi : 10.1093/eurheartj/ehab116
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 32–40
Peripheral artery disease (PAD) revascularization can be performed by either endovascular or open surgical approach. Despite increasing use of endovascular revascularization, it is still uncertain which strategy yields better long-term outcomes.
Christian-Alexander Behrendt
doi : 10.1093/eurheartj/ehab143
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 41–43
Umberto Benedetto, Arnaldo Dimagli, Amit Kaura, Mrcp, Shubhra Sinha, Giovanni Mariscalco, George Krasopoulos, Narain Moorjani, Mark Field, Trivedi Uday, Simon Kendal, Graham Cooper, Rakesh Uppal, Haris Bilal, Jorge Mascaro, Andrew Goodwin, Gianni Angelini, Geoffry Tsang,
doi : 10.1093/eurheartj/ehab586
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 44–52
Operability of type A acute aortic dissections (TAAAD) is currently based on non-standardized decision-making process, and it lacks a disease-specific risk evaluation model that can predict mortality. We investigated patient, intraoperative data, surgeon, and centre-related variables for patients who underwent TAAAD in the UK.
Martin Czerny, Bartosz Rylski
doi : 10.1093/eurheartj/ehab664
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 53–55
Rutao Wang, Patrick W Serruys, Chao Gao, Hironori Hara, Kuniaki Takahashi, Masafumi Ono, Hideyuki Kawashima, Neil O’leary, David R Holmes, Adam Witkowski, Nick Curzen, Francesco Burzotta, Stefan James, Robert-Jan van Geuns, Arie Pieter Kappetein, Marie-angele Morel, Stuart J Head, Daniel J F M Thuijs, Piroze M Davierwala, Timothy O’Brien, Valentin Fuster, Scot Garg, Yoshinobu Onuma
doi : 10.1093/eurheartj/ehab441
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 56–67
The aim of this article was to compare rates of all-cause death at 10 years following coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) in patients with or without diabetes.
William E Boden, Raffaele De Caterina, David P Taggart
doi : 10.1093/eurheartj/ehab445
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 68–70
Chetan Shenoy, John D Grizzard, Dipan J Shah, Mahwash Kassi, Michael J Reardon, Marianna Zagurovskaya, Han W Kim, Michele A Parker, Raymond J Kim
doi : 10.1093/eurheartj/ehab635
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 71–80
Cardiovascular magnetic resonance (CMR) imaging is a key diagnostic tool for the evaluation of patients with suspected cardiac tumours. Patient management is guided by the CMR diagnosis, including no further testing if a mass is excluded or if only a pseudomass is found. However, there are no outcomes studies validating this approach.
Sorin Giusca, Sebastian Kelle, Grigorios Korosoglou
doi : 10.1093/eurheartj/ehab625
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 81–83
Mattia Arrigo, Lars C Huber
doi : 10.1093/eurheartj/ehab762
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 84–85
Giorgio Maraziti, David R Vinson, Cecilia Becattini
doi : 10.1093/eurheartj/ehab779
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Pages 86–87
Tijn P J Jansen, Peter Damman, Robin Nijveldt
doi : 10.1093/eurheartj/ehab195
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Page 88
Enrico Cerrato, Federico Giacobbe, Giorgio Quadri, Fernando Macaya, Matteo Bianco, Ricardo Mori, Carlo Alberto Biolè, Alberto Boi, Luca Bettari, Cristina Rolfo, Fabio Ferrari, Gianmarco Annibali, Massimiliano Scappaticci, Marco Pavani, Umberto Barbero, Dario Buccheri, Chiara Cavallino, Primiano Lombardi, Chiara Bernelli, Fabrizio D’Ascenzo, Vincenzo Infantino, Alfonso Gambino, Sebastian Cinconze, Andrea Rognoni, Laura Montagna, Italo Porto, Giuseppe Musumeci, Javier Escaned, Ferdinando Varbella
doi : 10.1093/eurheartj/ehab720
European Heart Journal, Volume 43, Issue 1, 1 January 2022, Page 87
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟